Efficacy and Safety of Once-Daily Vilanterol/Fluticasone Furoate MDI in Persistent Asthma: Phase 3 OD-INHALE study

Conclusion: Once daily VI/FF pMDI was non-inferior to twice daily FOR/FP pMDI in patients with persistent asthma.PMID:38488853 | DOI:10.1080/02770903.2024.2330485

Source: Journal of Asthma - March 15, 2024 Category: Respiratory Medicine Authors: Avdhesh Kumar Manish Kumar Jain Vijaykumar Bhagwan Barge Raghumanda Sunil Kumar Neeraj Gupta Harendra Yadav Amitava Pal Vivek Eknath Redkar Asish Mondal Rahul Kumar Rathore Pavankumar Daultani Ashok Jaiswal Ravi T Mehta Source Type: research